Skip to main
EVO
EVO logo

Evotec SE (EVO) Stock Forecast & Price Target

Evotec SE (EVO) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 25%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Evotec has reported a notable increase in orders within its Discovery segment, which has risen by 70%, positioning the company for a revenue recovery projected for late 2024, particularly as this segment constitutes approximately 70% of the shared R&D revenues. In 2Q24, the company achieved total revenue of €182.1 million, reflecting a year-over-year growth of 7.0% compared to €170.3 million in the previous year, and anticipates significant growth in FY24 with double-digit revenue increases and mid-double-digit growth in adjusted EBITDA. The overall revenue for 2023 reached €781.4 million, marking a 4% year-over-year increase, with positive financial guidance indicating a strong outlook for continued expansion.

Bears say

Evotec reported a total revenue decline of 2.3% year-over-year for 1Q24, totaling €208.7 million, down from €213.6 million in the previous year. Additionally, the company's 2Q results showed a substantial 19% quarter-over-quarter decrease in revenue despite a 7% year-over-year increase, underlining a concerning volatility in revenue generation. Furthermore, Evotec's management retracted its prior mid-term targets for 2025 and provided lower-than-expected guidance for 2024, signaling potential challenges ahead in achieving sustainable growth and profitability.

Evotec SE (EVO) has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 25% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Evotec SE and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Evotec SE (EVO) Forecast

Analysts have given Evotec SE (EVO) a Buy based on their latest research and market trends.

According to 4 analysts, Evotec SE (EVO) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Evotec SE (EVO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.